KM, M., IA, L., I, S., MK, M., M, D., RJ, D., . . . AT, H. (2023). Sirolimus-eluting airway stent reduces profibrotic Th17 cells and inhibits laryngotracheal stenosis. JCI insight, 8(11), . https://doi.org/10.1172/jci.insight.158456
Chicago Style (17th ed.) CitationKM, Motz, et al. "Sirolimus-eluting Airway Stent Reduces Profibrotic Th17 Cells and Inhibits Laryngotracheal Stenosis." JCI Insight 8, no. 11 (2023). https://doi.org/10.1172/jci.insight.158456.
MLA (9th ed.) CitationKM, Motz, et al. "Sirolimus-eluting Airway Stent Reduces Profibrotic Th17 Cells and Inhibits Laryngotracheal Stenosis." JCI Insight, vol. 8, no. 11, 2023, https://doi.org/10.1172/jci.insight.158456.
Warning: These citations may not always be 100% accurate.